Christina Yau

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Abstract 1401: A novel statistical framework for surrogate endpoint prediction of survival in neoadjuvant breast cancer trials.

  Cancer Research · 2026-04-03

• Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trialPreprint

  Biometrics · 2026-03-28

• Classification of non-TCGA cancer samples to TCGA molecular subtypes using compact feature sets

  UNC Libraries · 2025-12-31

• Risk-Based vs Annual Breast Cancer Screening

  JAMA · 2025-12-12 · 34 citations

• Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors

  Nature Communications · 2025-12-09 · 6 citations

• Progesterone receptor ( <scp>PR</scp> ) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial

  International Journal of Cancer · 2025-10-24

• Abstract C051: Emerging Novel Targets to treat non-responding HER2-negative breast cancer patients: The neoadjuvant I-SPY2 TRIAL 2300 patient Omics data and organoid studies

  Molecular Cancer Therapeutics · 2025-10-22

• Data from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerPreprint

  2025-10-15

• Supplementary Tables 1 from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer

  2025-10-15

• Supplementary Figure 1 from Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast CancerPreprint

  2025-10-15

• Reducing Protocol Variability Enhances Predictive Performance of Breast MRI Biomarkers in a Multicenter Clinical Trial

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• Functional Tumor Volume by Subtype Improves Prediction of Pathological Complete Response in Breast Cancer

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• Validation of an MRI-Based Predictive Model for Treatment Tailoring in the I-SPY 2 Trial

  Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2025-09-16

• ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-29

• Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-23 · 2 citations

• ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

  Annals of Surgical Oncology · 2025-08-23

• Immune and Growth Factor Signaling Pathways Are Associated with Pathologic Complete Response to an Anti–Type I Insulin-like Growth Factor Receptor Regimen in Patients with Breast Cancer

  Clinical Cancer Research · 2025-08-11 · 3 citations

• Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial

  Annals of Surgical Oncology · 2025-07-24 · 5 citations

• Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial

  Annals of Surgical Oncology · 2025-07-23 · 1 citations

• Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second events

  npj Breast Cancer · 2025-07-01 · 3 citations